Healthcare & Life Sciences
Swixx Healthcare AG
Switzerland
series-c-plus
series-c-plus
Stage
1
Investors
About
Swixx Healthcare AG, operating as Swixx BioPharma, is a global commercial platform that partners with biopharma companies to commercialize innovative medicines, focusing on Central and Eastern Europe, CIS/Eurasia, MENAT, and Latin America regions, particularly in rare diseases, oncology-hematology, specialty care, and vaccines.
Explore Swixx Healthcare AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.